Family Office Of America, Revenue Growth Rates (FOFA), Current and Historic Growth - CSIMarket
CSIMarket
 


FAMILY OFFICE OF AMERICA, INC.  (OTC: FOFA)
 

FOFA's Revenue Growth by Quarter and Year

Family Office Of America,'s Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/FOFA/growth
https://api.csimarket.com/api/v1/companies/FOFA/fundamentals
https://api.csimarket.com/api/v1/companies/FOFA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
FOFA Revenue (in millions $) FY 2027 FY 2026 FY 2025 FY 2024
4th Quarter December -
3rd Quarter September 0.40
2nd Quarter June 0.53
1st Quarter March 0.78
FY 1.71





FOFA Revenue third quarter 2027 Y/Y Growth Comment
FAMILY OFFICE OF AMERICA, INC. in the third quarter 2027 achieved Revenue of $ 0.40 millions compare to recorded in same quarter a year ago.

According to the results reported in the third quarter 2027, Family Office Of America, Inc. achieved the best Revenue growth in Medical Equipment & Supplies industry. While Family Office Of America, Inc.' s Revenue no change of 0% ranks overall at the positon no. in the third quarter 2027.




FOFA Revenue ( Y/Y Growth %) 2027
FY 2026 FY 2025 FY 2024
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March -
FY   -

Financial Statements
Family Office Of America,'s third quarter 2027 Revenue $ 0.40 millions FOFA's Income Statement
Family Office Of America,'s third quarter 2026 Revenue $ 0.00 millions Quarterly FOFA's Income Statement


FOFA Revenue (Quarter on Quarter Growth %)

2027
FY 2026 FY 2025 FY 2024
4th Quarter December -
3rd Quarter September -24.95 %
2nd Quarter June -32.05 %
1st Quarter March 254.55 %
FY (Year on Year)   -




Revenue third quarter 2027 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
(Mar 31 2026)   (Jun 30 2026)
Revenue third quarter 2027 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
(Mar 31 2026)   (Jun 30 2026)

Revenue by Quarter for the Fiscal Years 2024, 2025, 2026, 2027

Family Office Of America,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
253.07 % 65.25 % -31.98 %
(Mar 31 2026)  


FOFA's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2027 Family Office Of America, Inc. disclosed fall in Revenue from the second quarter by -24.95% to $ 0.40 millions, from $ 0.53 millions achived in the previous reporting period.

Within Medical Equipment & Supplies industry FAMILY OFFICE OF AMERICA, INC. achieved highest sequential Revenue growth. While Family Office Of America,'s Revenue growth quarter on quarter, overall rank is 0.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #0
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #0
Revenue Q/Q Growth Statistics
High Average Low
253.07 % 65.25 % -31.98 %
(Mar 31 2026)  


FOFA's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2027 Family Office Of America, Inc. disclosed fall in Revenue from the second quarter by -24.95% to $ 0.40 millions, from $ 0.53 millions achived in the previous reporting period.

Within Medical Equipment & Supplies industry FAMILY OFFICE OF AMERICA, INC. achieved highest sequential Revenue growth. While Family Office Of America,'s Revenue growth quarter on quarter, overall rank is 0.


Family Office Of America,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)
12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 1.94
Y / Y Revenue Growth (TTM) -
Year on Year Revenue Growth Overall Ranking #
Seqeuential Revenue Change (TTM) -
Seq. Revenue Growth (TTM) Overall Ranking #


Cumulative Revenue growth Comment


FAMILY OFFICE OF AMERICA, INC. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment


FAMILY OFFICE OF AMERICA, INC. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
FOFA's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Nuwellis Inc -0.23%$ -0.226 millions
Viatris Inc -0.28%$ -0.277 millions
Zoetis Inc -0.38%$ -0.375 millions
Pfizer Inc-0.43%$ -0.426 millions
Standard Biotools Inc -0.51%$ -0.508 millions
Lucid Diagnostics Inc -0.66%$ -0.661 millions
Globus Medical Inc -0.69%$ -0.693 millions
Conmed Corporation-0.70%$ -0.701 millions
Surgery Partners Inc -0.75%$ -0.755 millions
Myriad Genetics Inc -1.03%$ -1.025 millions
Lensar Inc -1.29%$ -1.292 millions
Fortrea Holdings Inc -1.40%$ -1.397 millions
Immunocore Holdings Plc-1.42%$ -1.419 millions
Pacira Biosciences inc -1.59%$ -1.595 millions
Organon and Co -1.75%$ -1.748 millions
Teva Pharmaceutical Industries Limited-1.90%$ -1.897 millions
Skinhealth Systems Inc -2.07%$ -2.071 millions
Charles River Laboratories International inc -2.20%$ -2.201 millions
Inogen Inc -2.40%$ -2.399 millions
Novavax inc -3.05%$ -3.048 millions
Seer Inc -3.14%$ -3.139 millions
Teladoc Health Inc -3.41%$ -3.406 millions
Scientific Industries Inc -3.50%$ -3.504 millions
Cg Oncology Inc -3.72%$ -3.721 millions
Treace Medical Concepts Inc -3.91%$ -3.905 millions
Sarepta Therapeutics Inc -4.51%$ -4.509 millions
Pacific Health Care Organization Inc-4.69%$ -4.689 millions
Tela Bio Inc -5.06%$ -5.058 millions
Perrigo Company Plc-5.22%$ -5.225 millions
Heron Therapeutics Inc -5.49%$ -5.493 millions


About Family Office Of America, Revenue Growth Rates (FOFA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Family Office Of America Inc (CIK 1871181).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-26-051973
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Family Office Of America Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.